# NAD+ Precursors (NMN / NR) - Clinical Longevity Review & Consensus Audit

> **Consensus Verdict**: Nicotinamide Mononucleotide (NMN) is an immediate biosimilar precursor to Nicotinamide Adenine Dinucleotide (NAD+), which declines by up to 50% between age 20 and 60. In human clinical trials, oral NMN supplementation (250–1000 mg daily) significantly elevates whole-blood NAD+ levels within 2–4 weeks, enhances skeletal muscle insulin sensitivity (+25% in postmenopausal women in Science 2021), improves 6-minute walk distance, and restores cerebromicrovascular endothelial function.

## 1. Executive Summary & Scores
- **Longevity Evidence Score**: **91/100**
- **Evidence Quality Tier**: **silver**
- **Human Clinical Evidence Strength**: 92/100
- **Primary Longevity Classification**: supplements
- **Safety Margin Score**: 90/100 (Higher is safer)
- **Time Burden**: ~1 minutes/day
- **Estimated Monthly Cost**: moderate
- **Adherence Friction**: 2/10 (Lower is easier to sustain)

---

## 2. Biological Mechanisms of Action
The restoration of optimal intracellular NAD+ pools directly fuels the activity of three major, highly conserved consumer enzyme classes that govern longevity. First are the Sirtuins (histone deacetylases that regulate epigenetic silencing, circadian rhythms, and massive mitochondrial biogenesis)11. Second are the Poly (ADP-ribose) polymerases (PARPs), which act as rapid-response genomic paramedics, heavily recruited to sites of DNA strand breaks to initiate structural repair11. Finally, the CD38/CD157 ectoenzymes, which govern calcium mobilization, stem cell proliferation, and immune cell function11. By fully replenishing the NAD+ metabolome, high-dose NMN effectively counteracts age-induced bioenergetic decline, restores vascular endothelial function, and provides the molecular "fuel" required to maintain a healthy, resilient cellular lifespan5.

---

## 3. Canonical Longevity Vector Impacts (The 8 Longevity Pillars)
- **Cellular Longevity & Autophagy**: **82/100** [Rank #50 of 131 in Cellular] - Effect: Maintains genomic stability, telomeric integrity, extracellular collagen matrix, and mitochondrial proteostasis
    - Mechanism: Activates nuclear transcription factors (SIRT1/RAR), photobiomodulates cytochrome c oxidase, or enhances DNA strand break repair.

---

## 4. Practical Protocol & Administration Guidelines
- **Standard Clinical Dosage**: 300-1000mg
- **Recommended Timing**: Morning with breakfast
- **Administration Type**: supplement
- **Recommended Biomarkers to Monitor**: energy, endurance, brain_fog, sleep_quality, cellular_longevity

---

## 5. Safety, Contraindications & Drug Interactions
- **Contraindications**: Active cancers (theoretical risk)
- **Safety Profile**: low_risk - Well tolerated within physiological ranges.

---

## 6. Peer-Reviewed Human Clinical Trials & Key PMIDs
1. **Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women** [PMID: 33888596]
   - Link: https://pubmed.ncbi.nlm.nih.gov/33888596/
2. **Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study** [PMID: 34238308]
   - Link: https://pubmed.ncbi.nlm.nih.gov/34238308/
3. **Effect of 12-Week Intake of Nicotinamide Mononucleotide on Sleep Quality, Fatigue, and Physical Performance in Older Japanese Adults: A Randomized, Double-Blind Placebo-Controlled Study** [PMID: 36014894]
   - Link: https://pubmed.ncbi.nlm.nih.gov/36014894/
4. **NAD+ Intermediates and Longevity Therapeutics** [PMID: 30894380]
   - Link: https://pubmed.ncbi.nlm.nih.gov/30894380/

---

## 7. Canonical Citation & Web Verification
- **Official Web Review**: [NAD+ Precursors (NMN / NR) on LongevityReviews](https://longevityreviews.org/modalities/nad_precursors)
- **Last Evidence Calibration**: 2026-08-04
- **Review Policy**: 0% sponsored placements, independent peer-reviewed consensus.